Get started
Author

Nyashadzaishe Mafirakureva

Observed names: Mafirakureva, N., Mafirakureva, Nyashadzaishe, N. Mafirakureva, Nyasha Mafirakureva
Observed institutions: University of Zimbabwe, University of Groningen, University of Bristol, St Vincent's Hospital Melbourne, National Blood Service Zimbabwe, Midlands State University, University of Sheffield
ORCID: 0000-0001-9775-6581
Observed ORCID: 0000-0001-9775-6581
OpenAlex ID: A5004237130
Health-related quality of life in HIV/AIDS patients on antiretroviral therapy at a tertiary care facility in Zimbabwe
2016 · N. Mafirakureva, B. Dzingirai, et al. · AIDS Care · 51
PDF
Effects and cost of different strategies to eliminate hepatitis C virus transmission in Pakistan: a modelling analysis
2020 · Aaron G Lim, Josephine G Walker, et al. · The Lancet Global Health · 41
PDF
Effectiveness of a community-based approach for the investigation and management of children with household tuberculosis contact in Cameroon and Uganda: a cluster-randomised trial
2023 · Maryline Bonnet, Anca Vasiliu, et al. · The Lancet Global Health · 38
The global impact of household contact management for children on multidrug-resistant and rifampicin-resistant tuberculosis cases, deaths, and health-system costs in 2019: a modelling study
2022 · Peter J Dodd, Nyashadzaishe Mafirakureva, et al. · The Lancet Global Health · 37
PDF
Profiles of blood and blood component transfusion recipients in Zimbabwe.
2015 · Nyashadzaishe Mafirakureva, Star Khoza, et al. · PubMed · 36
Incidence and pattern of 12 years of reported transfusion adverse events in Zimbabwe: a retrospective analysis.
2014 · Nyashadzaishe Mafirakureva, Star Khoza, et al. · PubMed · 31
Xpert Ultra stool testing to diagnose tuberculosis in children in Ethiopia and Indonesia: a model-based cost-effectiveness analysis
2022 · Nyashadzaishe Mafirakureva, Eveline Klinkenberg, et al. · BMJ Open · 30
PDF
The costs of producing a unit of blood in Z imbabwe
2015 · Nyashadzaishe Mafirakureva, Herbert Nyoni, et al. · Transfusion · 27
Cost and cost‐effectiveness of a simplified treatment model with direct‐acting antivirals for chronic hepatitis C in Cambodia
2020 · Josephine G. Walker, Nyashadzaishe Mafirakureva, et al. · Liver International · 25
PDF
Fractures in sub-Saharan Africa: epidemiology, economic impact and ethnography (Fractures-E3): study protocol
2023 · Anya Burton, Sarah Drew, et al. · Wellcome Open Research · 22
Modelling the impact of HIV and hepatitis C virus prevention and treatment interventions among people who inject drugs in Kenya
2022 · Jack Stone, Hannah Fraser, et al. · AIDS · 21
Global estimates of tuberculosis incidence during pregnancy and postpartum: a rapid review and modelling analysis
2026 · Nyashadzaishe Mafirakureva, Anna Cartledge, et al. · The Lancet Global Health · 19
Population Pharmacokinetic-Pharmacodynamic Modeling of Haloperidol in Patients With Schizophrenia Using Positive and Negative Syndrome Rating Scale
2013 · Venkatesh Pilla Reddy, Magdalena Kozielska, et al. · Journal of Clinical Psychopharmacology · 19
Cost-effectiveness of mass screening for Hepatitis C virus among all inmates in an Irish prison
2021 · Zoe Ward, Nyashadzaishe Mafirakureva, et al. · International Journal of Drug Policy · 17
Cost‐effectiveness of screening and treatment using direct‐acting antivirals for chronic Hepatitis C virus in a primary care setting in Karachi, Pakistan
2020 · Nyashadzaishe Mafirakureva, Aaron G. Lim, et al. · Journal of Viral Hepatitis · 16
PDF
Feasibility of a randomized clinical trial evaluating a community intervention for household tuberculosis child contact management in Cameroon and Uganda
2022 · Anca Vasiliu, Georges Tiendrebeogo, et al. · Pilot and Feasibility Studies · 14
PDF
An intensive model of care for hepatitis C virus screening and treatment with direct‐acting antivirals in people who inject drugs in Nairobi, Kenya: a model‐based cost‐effectiveness analysis
2021 · Nyashadzaishe Mafirakureva, Jack Stone, et al. · Addiction · 14
Cost effectiveness of adding nucleic acid testing to hepatitis B , hepatitis C , and human immunodeficiency virus screening of blood donations in Z imbabwe
2016 · Nyashadzaishe Mafirakureva, Tonderai Mapako, et al. · Transfusion · 14
Cost-effectiveness of community-based household tuberculosis contact management for children in Cameroon and Uganda: a modelling analysis of a cluster-randomised trial
2023 · Nyashadzaishe Mafirakureva, Boris K Tchounga, et al. · The Lancet Global Health · 13
Progress on the elimination of viral hepatitis in Zimbabwe: A review of the policies, strategies and challenges
2021 · Blessing Dzingirai, Leolin Katsidzira, et al. · Journal of Viral Hepatitis · 13
PDF
The healthcare system costs of hip fracture care in South Africa
2023 · N. Mafirakureva, F. Paruk, et al. · Osteoporosis International · 12
Cost-effectiveness and budget impact of decentralising childhood tuberculosis diagnosis in six high tuberculosis incidence countries: a mathematical modelling study
2024 · Marc d’Elbée, Martin Harker, et al. · EClinicalMedicine · 9
PDF
Cost and cost-effectiveness of a real-world HCV treatment program among HIV-infected individuals in Myanmar
2021 · Lara K Marquez, Antoine Chaillon, et al. · BMJ Global Health · 8
PDF
Cost-effectiveness analysis of interventions to improve diagnosis and preventive therapy for paediatric tuberculosis in 9 sub-Saharan African countries: A modelling study
2023 · Nyashadzaishe Mafirakureva, Sushant Mukherjee, et al. · PLoS Medicine · 6
PDF
Cost-effectiveness of tuberculosis infection screening at first reception into English prisons: a model-based analysis
2025 · Nyashadzaishe Mafirakureva, Rachael Hunter, et al. · EClinicalMedicine · 5
PDF
Works count: 63
Citation count: 595
H-index: 15
I10-index: 21
Year
Topic
Type